Literature DB >> 16873022

Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules.

Anke Kiessling1, Bianca Sperl, Angela Hollis, Dirk Eick, Thorsten Berg.   

Abstract

bZip and bHLHZip protein family members comprise a large fraction of eukaryotic transcription factors and need to bind DNA in order to exert most of their fundamental biological roles. Their binding to DNA requires homo- or heterodimerization via alpha-helical domains, which generally do not contain obvious binding sites for small molecules. We have identified two small molecules, dubbed Mycro1 and Mycro2, which inhibit the protein-protein interactions between the bHLHZip proteins c-Myc and Max. Mycros are the first inhibitors of c-Myc/Max dimerization, which have been demonstrated to inhibit DNA binding of c-Myc with preference over other dimeric transcription factors in vitro. Mycros inhibit c-Myc-dependent proliferation, gene transcription, and oncogenic transformation in the low micromolar concentration range. Our data support the idea that dimeric transcription factors can be druggable even in the absence of obvious small-molecule binding pockets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873022     DOI: 10.1016/j.chembiol.2006.05.011

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  58 in total

Review 1.  Understanding protein non-folding.

Authors:  Vladimir N Uversky; A Keith Dunker
Journal:  Biochim Biophys Acta       Date:  2010-02-01

Review 2.  Transcription Factor Inhibition: Lessons Learned and Emerging Targets.

Authors:  Andrew Chen; Angela N Koehler
Journal:  Trends Mol Med       Date:  2020-02-15       Impact factor: 11.951

3.  Chemical genetics: reshaping biology through chemistry.

Authors:  Stefan Florian; Stefan Hümmer; Mario Catarinella; Thomas U Mayer
Journal:  HFSP J       Date:  2007-07-12

Review 4.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

5.  A general method for discovering inhibitors of protein-DNA interactions using photonic crystal biosensors.

Authors:  Leo L Chan; Maria Pineda; James T Heeres; Paul J Hergenrother; Brian T Cunningham
Journal:  ACS Chem Biol       Date:  2008-07-18       Impact factor: 5.100

6.  Sin3b interacts with Myc and decreases Myc levels.

Authors:  Pablo Garcia-Sanz; Andrea Quintanilla; M Carmen Lafita; Gema Moreno-Bueno; Lucia García-Gutierrez; Vedrana Tabor; Ignacio Varela; Yuzuru Shiio; Lars-Gunnar Larsson; Francisco Portillo; Javier Leon
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

Review 7.  Intrinsically disordered proteins are potential drug targets.

Authors:  Steven J Metallo
Journal:  Curr Opin Chem Biol       Date:  2010-07-02       Impact factor: 8.822

Review 8.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

9.  Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model.

Authors:  Gabriela Mustata; Ariele Viacava Follis; Dalia I Hammoudeh; Steven J Metallo; Huabo Wang; Edward V Prochownik; John S Lazo; Ivet Bahar
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

10.  Discovery of selective inhibitors against EBNA1 via high throughput in silico virtual screening.

Authors:  Ning Li; Scott Thompson; David C Schultz; Weiliang Zhu; Hualiang Jiang; Cheng Luo; Paul M Lieberman
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.